Novavax, Inc.
NASDAQ:NVAX
$1.27
$0.02
(1.60%)
Related Resources
NVAX
vs. S&P 500
|
$1.27
$0.02
(1.60%)
|
|
| Today's Open | $1.24 |
|---|---|
| Previous Close | $1.25 |
| Daily Range | $1.22 - $1.28 |
| 52-Week Range | $1.12 - $2.45 |
| Market Cap | $155.1M |
| P/E Ratio | -7.81 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 358,656 |
| Average Daily Volume | 985,110 |
| Current FY EPS | -$0.19 |
Sector
Healthcare
Industry
Biotechnology
Description
A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.
